Skip to main content
Top
Published in: Pain and Therapy 2/2017

Open Access 01-12-2017 | Review

Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis

Authors: Panagiotis Zis, Antonella Paladini, Alba Piroli, Patrick C. McHugh, Giustino Varrassi, Marios Hadjivassiliou

Published in: Pain and Therapy | Issue 2/2017

Login to get access

Abstract

Introduction

Paraneoplastic neurological syndromes (PNS) consist of a heterogeneous group of neurological disorders triggered by cancer. The aim of this systematic review is to estimate the reported prevalence of pain in patients with paraneoplastic peripheral neuropathy (PPN).

Methods

A systematic computer-based literature search was conducted on PubMed database.

Results

Our search strategy resulted in the identification of 126 articles. After the eligibility assessment, 45 papers met the inclusion criteria. Full clinical and neurophysiological data were further extracted and involved 92 patients with PPN (54.5% males, mean age 60.0 ± 12.2 years). The commonest first manifestation of PPN is sensory loss (67.4%), followed by pain (41.3%), weakness (22.8%), and sensory ataxia (20.7%). In 13.0% of the cases, pain was the sole first manifestation of the PPN. During the course of the PPN, 57.6% of the patients may experience pain secondary to the neuropathy.

Conclusions

Pain is very prevalent within PPN. Pain specialists should be aware of this. Detailed history-taking, full clinical examination, and requesting nerve conduction studies might lead to an earlier diagnosis of an underlying malignancy.
Literature
1.
go back to reference Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543–54.CrossRefPubMed Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543–54.CrossRefPubMed
2.
go back to reference Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135–40.CrossRefPubMedPubMedCentral Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135–40.CrossRefPubMedPubMedCentral
3.
go back to reference Donofrio PD, Albers JW, Greenberg HS, Mitchell BS. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy. Muscle Nerve. 1984;7(2):137–41.CrossRefPubMed Donofrio PD, Albers JW, Greenberg HS, Mitchell BS. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy. Muscle Nerve. 1984;7(2):137–41.CrossRefPubMed
4.
go back to reference Gherardi R, Gaulard P, Prost C, Rocha D, Imbert M, Andre C, Rochant H, Farcet JP. T-Cell lymphoma revealed by a peripheral neuropathy: a report of two cases with an immunohistologic study on lymph node and nerve biopsies. Cancer. 1986;58(12):2710–6.CrossRefPubMed Gherardi R, Gaulard P, Prost C, Rocha D, Imbert M, Andre C, Rochant H, Farcet JP. T-Cell lymphoma revealed by a peripheral neuropathy: a report of two cases with an immunohistologic study on lymph node and nerve biopsies. Cancer. 1986;58(12):2710–6.CrossRefPubMed
5.
go back to reference Oh SJ, Slaughter R, Harrell L. Paraneoplastic vasculitic neuropathy: a treatable neuropathy. Muscle Nerve. 1991;14(2):152–6.CrossRefPubMed Oh SJ, Slaughter R, Harrell L. Paraneoplastic vasculitic neuropathy: a treatable neuropathy. Muscle Nerve. 1991;14(2):152–6.CrossRefPubMed
6.
go back to reference Elrington GM, Murray NM, Spiro SG, Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry. 1991;54(9):764–7.CrossRefPubMedPubMedCentral Elrington GM, Murray NM, Spiro SG, Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry. 1991;54(9):764–7.CrossRefPubMedPubMedCentral
7.
go back to reference Dalmau J, Graus F, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine. 1992;71(2):59–72.CrossRefPubMed Dalmau J, Graus F, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine. 1992;71(2):59–72.CrossRefPubMed
8.
go back to reference Plante-Bordeneuve V, Baudrimont M, Gorin NC, Gherardi RK. Subacute sensory neuropathy associated with Hodgkin’s disease. J Neurol Sci. 1994;121(2):155–8.CrossRefPubMed Plante-Bordeneuve V, Baudrimont M, Gorin NC, Gherardi RK. Subacute sensory neuropathy associated with Hodgkin’s disease. J Neurol Sci. 1994;121(2):155–8.CrossRefPubMed
9.
go back to reference Dropcho EJ. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol. 1996;39(5):659–67.CrossRefPubMed Dropcho EJ. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol. 1996;39(5):659–67.CrossRefPubMed
10.
go back to reference Aoshima H, Kushida K, Okada M, Kageyama Y, Inoue T, Tomita H. Neuropathic arthropathy caused by paraneoplastic sensory neuropathy: a case report. Clin Orthop Relat Res. 1997;1(339):185–9.CrossRef Aoshima H, Kushida K, Okada M, Kageyama Y, Inoue T, Tomita H. Neuropathic arthropathy caused by paraneoplastic sensory neuropathy: a case report. Clin Orthop Relat Res. 1997;1(339):185–9.CrossRef
11.
go back to reference Toepfer M, Schroeder M, Unger JW, Lochmüller H, Pongratz D, Müller-Felber W. Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies). Clin Neurol Neurosurg. 1999;101(3):207–9.CrossRefPubMed Toepfer M, Schroeder M, Unger JW, Lochmüller H, Pongratz D, Müller-Felber W. Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies). Clin Neurol Neurosurg. 1999;101(3):207–9.CrossRefPubMed
12.
go back to reference Behringer D, Spyridonidis A, Fetscher S, Schmitt-Gräff A, Högerle S, Kaiser R. Paraneoplastic polyneuropathy preceding the diagnosis of Hodgkin’s disease and non-small cell lung cancer in a patient with concomitant Borrelia burgdorferi infection. Ann Hematol. 2001;80(4):232–5.CrossRefPubMed Behringer D, Spyridonidis A, Fetscher S, Schmitt-Gräff A, Högerle S, Kaiser R. Paraneoplastic polyneuropathy preceding the diagnosis of Hodgkin’s disease and non-small cell lung cancer in a patient with concomitant Borrelia burgdorferi infection. Ann Hematol. 2001;80(4):232–5.CrossRefPubMed
13.
go back to reference Winkler AS, Dean A, Hu M, Gregson N, Chaudhuri KR. Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases. Clin Auton Res. 2001;11(2):115–8.CrossRefPubMed Winkler AS, Dean A, Hu M, Gregson N, Chaudhuri KR. Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases. Clin Auton Res. 2001;11(2):115–8.CrossRefPubMed
14.
go back to reference Farrugia ME. Negative-antibody paraneoplastic syndrome complicating small cell carcinoma. Scott Med J. 2001;46(4):117–8.CrossRefPubMed Farrugia ME. Negative-antibody paraneoplastic syndrome complicating small cell carcinoma. Scott Med J. 2001;46(4):117–8.CrossRefPubMed
15.
go back to reference Suzuki M, Kimura H, Tachibana I, Fujimura H, Nakatsuji Y, Sugai F, Nakamori M, Morishita H, Toru AR, Osaki T, Hayashi S. Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient. Intern Med. 2001;40(11):1140–3.CrossRefPubMed Suzuki M, Kimura H, Tachibana I, Fujimura H, Nakatsuji Y, Sugai F, Nakamori M, Morishita H, Toru AR, Osaki T, Hayashi S. Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient. Intern Med. 2001;40(11):1140–3.CrossRefPubMed
16.
go back to reference Camdessanché JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, Michel D. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. Brain. 2002;125(1):166–75.CrossRefPubMed Camdessanché JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, Michel D. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. Brain. 2002;125(1):166–75.CrossRefPubMed
17.
go back to reference Ivanaj A, Pautier P, Rixe O, Duvillard P, Dubard T. Peripheral neuropathy in association with an ovarian dysgerminoma. Gynecol Oncol. 2003;89(1):168–70.CrossRefPubMed Ivanaj A, Pautier P, Rixe O, Duvillard P, Dubard T. Peripheral neuropathy in association with an ovarian dysgerminoma. Gynecol Oncol. 2003;89(1):168–70.CrossRefPubMed
18.
go back to reference Altaha R, Abraham J. Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literature. Breast J. 2003;9(5):417–9.CrossRefPubMed Altaha R, Abraham J. Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literature. Breast J. 2003;9(5):417–9.CrossRefPubMed
19.
go back to reference Ogawa M, Nishie M, Kurahashi K, Kaimori M, Wakabayashi K. Anti-Hu associated paraneoplastic sensory neuronopathy with upper motor neurone involvement. J Neurol Neurosurg Psychiatry. 2004;75(7):1051–3.CrossRefPubMedPubMedCentral Ogawa M, Nishie M, Kurahashi K, Kaimori M, Wakabayashi K. Anti-Hu associated paraneoplastic sensory neuronopathy with upper motor neurone involvement. J Neurol Neurosurg Psychiatry. 2004;75(7):1051–3.CrossRefPubMedPubMedCentral
20.
go back to reference Kiylioglu N, Meydan N, Barutca S, Akyol A. Sub-acute sensory neuronopathy as a preceding sign of recurrence in colon carcinoma. Int J Gastrointest Cancer. 2003;34(2–3):135–7.CrossRefPubMed Kiylioglu N, Meydan N, Barutca S, Akyol A. Sub-acute sensory neuronopathy as a preceding sign of recurrence in colon carcinoma. Int J Gastrointest Cancer. 2003;34(2–3):135–7.CrossRefPubMed
21.
go back to reference Raaphorst J, Vanneste J. Numb cheek syndrome as the first manifestation of anti-Hu paraneoplastic neuronopathy. J Neurol. 2006;253(5):664–5.CrossRefPubMed Raaphorst J, Vanneste J. Numb cheek syndrome as the first manifestation of anti-Hu paraneoplastic neuronopathy. J Neurol. 2006;253(5):664–5.CrossRefPubMed
22.
go back to reference Schilstra A, van Tuijl JH, van Suylen RJ, Faber CG, ten Velde GP. Unclassified rhabdomyosarcoma in a patient with anti-Hu syndrome. Acta Clin Belg. 2005;60(5):248–51.CrossRefPubMed Schilstra A, van Tuijl JH, van Suylen RJ, Faber CG, ten Velde GP. Unclassified rhabdomyosarcoma in a patient with anti-Hu syndrome. Acta Clin Belg. 2005;60(5):248–51.CrossRefPubMed
23.
go back to reference Martin AC, Friedlander M, Kiernan MC. Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma. J Clin Neurosci. 2006;13(5):595–8.CrossRefPubMed Martin AC, Friedlander M, Kiernan MC. Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma. J Clin Neurosci. 2006;13(5):595–8.CrossRefPubMed
24.
go back to reference Coppens T, Van den Bergh P, Duprez TJ, Jeanjean A, De Ridder F, Sindic CJ. Paraneoplastic rhombencephalitis and brachial plexopathy in two cases of amphiphysin auto-immunity. Eur Neurol. 2006;55(2):80–3.CrossRefPubMed Coppens T, Van den Bergh P, Duprez TJ, Jeanjean A, De Ridder F, Sindic CJ. Paraneoplastic rhombencephalitis and brachial plexopathy in two cases of amphiphysin auto-immunity. Eur Neurol. 2006;55(2):80–3.CrossRefPubMed
25.
go back to reference Oki Y, Koike H, Iijima M, Mori K, Hattori N, Katsuno M, Nakamura T, Hirayama M, Tanaka F, Shiraishi M, Yazaki S. Ataxic vs painful form of paraneoplastic neuropathy. Neurology. 2007;69(6):564–72.CrossRefPubMed Oki Y, Koike H, Iijima M, Mori K, Hattori N, Katsuno M, Nakamura T, Hirayama M, Tanaka F, Shiraishi M, Yazaki S. Ataxic vs painful form of paraneoplastic neuropathy. Neurology. 2007;69(6):564–72.CrossRefPubMed
26.
go back to reference Schrader C, Alwan G, Weissenborn K. Pseudochoreoathetosis can be the first clinical manifestation of anti-Hu-neuropathy associated with squamous cell carcinoma. Mov Disord. 2008;23(15):2257–9.CrossRefPubMed Schrader C, Alwan G, Weissenborn K. Pseudochoreoathetosis can be the first clinical manifestation of anti-Hu-neuropathy associated with squamous cell carcinoma. Mov Disord. 2008;23(15):2257–9.CrossRefPubMed
27.
go back to reference Coret F, Bosca I, Fratalia L, Perez-Griera J, Pascual A, Casanova B. Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction. J Neurooncol. 2009;93(3):421–3.CrossRefPubMed Coret F, Bosca I, Fratalia L, Perez-Griera J, Pascual A, Casanova B. Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction. J Neurooncol. 2009;93(3):421–3.CrossRefPubMed
28.
go back to reference Santangeli P, Pieroni M, Marzo F, Frontera A, Vitulano N, Luciani N, Bellocci F, Crea F. Cardiac myxoma presenting with sensory neuropathy. Int J Cardiol. 2010;143(1):e14–6.CrossRefPubMed Santangeli P, Pieroni M, Marzo F, Frontera A, Vitulano N, Luciani N, Bellocci F, Crea F. Cardiac myxoma presenting with sensory neuropathy. Int J Cardiol. 2010;143(1):e14–6.CrossRefPubMed
29.
go back to reference Rajabally YA, Qaddoura B, Abbott RJ. Steroid-responsive paraneoplastic demyelinating neuropathy and myelopathy associated with breast carcinoma. J Clin Neuromuscul Dis. 2008;10(2):65–9.CrossRefPubMed Rajabally YA, Qaddoura B, Abbott RJ. Steroid-responsive paraneoplastic demyelinating neuropathy and myelopathy associated with breast carcinoma. J Clin Neuromuscul Dis. 2008;10(2):65–9.CrossRefPubMed
30.
go back to reference Uribe-Uribe NO, Jimenez-Garduño AM, Henson DE, Albores-Saavedra J. Paraneoplastic sensory neuropathy associated with small cell carcinoma of the gallbladder. Ann Diagn Pathol. 2009;13(2):124–6.CrossRefPubMed Uribe-Uribe NO, Jimenez-Garduño AM, Henson DE, Albores-Saavedra J. Paraneoplastic sensory neuropathy associated with small cell carcinoma of the gallbladder. Ann Diagn Pathol. 2009;13(2):124–6.CrossRefPubMed
31.
go back to reference López JL, Amezcua S, Pascual J, Algara M. Acute motor axonal neuropathy associated with anal carcinoma: paraneoplastic neurological syndrome or coincidence? Rep Pract Oncol Radiother. 2011;16(2):54–7.CrossRefPubMedPubMedCentral López JL, Amezcua S, Pascual J, Algara M. Acute motor axonal neuropathy associated with anal carcinoma: paraneoplastic neurological syndrome or coincidence? Rep Pract Oncol Radiother. 2011;16(2):54–7.CrossRefPubMedPubMedCentral
32.
go back to reference Samarasekera S, Rajabally YA. Demyelinating neuropathy with anti-CRMP5 antibodies predating diagnosis of breast carcinoma: favorable outcome after cancer therapy. Muscle Nerve. 2011;43(5):764–6.CrossRefPubMed Samarasekera S, Rajabally YA. Demyelinating neuropathy with anti-CRMP5 antibodies predating diagnosis of breast carcinoma: favorable outcome after cancer therapy. Muscle Nerve. 2011;43(5):764–6.CrossRefPubMed
33.
go back to reference Kawanishi K, Ohyama Y, Kanai Y, Hirase T, Tanaka H, Miyatake J, Tatsumi Y, Ashida T, Nakamine H, Matsumura I. Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). Intern Med. 2012;51(15):2015–20.CrossRefPubMed Kawanishi K, Ohyama Y, Kanai Y, Hirase T, Tanaka H, Miyatake J, Tatsumi Y, Ashida T, Nakamine H, Matsumura I. Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). Intern Med. 2012;51(15):2015–20.CrossRefPubMed
34.
go back to reference Flanagan EP, Sandroni P, Inwards DJ, Jones LK. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012;46(5):823–7.CrossRefPubMed Flanagan EP, Sandroni P, Inwards DJ, Jones LK. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012;46(5):823–7.CrossRefPubMed
35.
go back to reference Porto L, Miranda M, Gomes A, André R, Rodrigues B. Paraneoplastic neurological syndrome as an initial indicator of small cell carcinoma of the lung. BMJ Case Rep. 2013;2013:bcr2012008432.PubMedPubMedCentral Porto L, Miranda M, Gomes A, André R, Rodrigues B. Paraneoplastic neurological syndrome as an initial indicator of small cell carcinoma of the lung. BMJ Case Rep. 2013;2013:bcr2012008432.PubMedPubMedCentral
36.
go back to reference Tomita M, Koike H, Kawagashira Y, Iijima M, Adachi H, Taguchi J, Abe T, Sako K, Tsuji Y, Nakagawa M, Kanda F. Clinicopathological features of neuropathy associated with lymphoma. Brain. 2013;136(8):2563–78.CrossRefPubMed Tomita M, Koike H, Kawagashira Y, Iijima M, Adachi H, Taguchi J, Abe T, Sako K, Tsuji Y, Nakagawa M, Kanda F. Clinicopathological features of neuropathy associated with lymphoma. Brain. 2013;136(8):2563–78.CrossRefPubMed
37.
go back to reference Koike H, Yoshida H, Ito T, Ohyama K, Hashimoto R, Kawagashira Y, Iijima M, Sobue G. Demyelinating neuropathy and autoimmune hemolytic anemia in a patient with pancreatic cancer. Intern Med. 2013;52(15):1737–40.CrossRefPubMed Koike H, Yoshida H, Ito T, Ohyama K, Hashimoto R, Kawagashira Y, Iijima M, Sobue G. Demyelinating neuropathy and autoimmune hemolytic anemia in a patient with pancreatic cancer. Intern Med. 2013;52(15):1737–40.CrossRefPubMed
38.
go back to reference Hughes CL, Yorio JT, Kovitz C, Oki Y. Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report. J Med Case Rep. 2014;8(1):455.CrossRefPubMedPubMedCentral Hughes CL, Yorio JT, Kovitz C, Oki Y. Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report. J Med Case Rep. 2014;8(1):455.CrossRefPubMedPubMedCentral
39.
go back to reference Kannan MA, Challa S, Kandadai RM, Uppin MS, Jabeen SA, Borgohain R. Series of paraneoplastic vasculitic neuropathy: a rare, potentially treatable neuropathy. Neurol India. 2015;63(1):30.CrossRefPubMed Kannan MA, Challa S, Kandadai RM, Uppin MS, Jabeen SA, Borgohain R. Series of paraneoplastic vasculitic neuropathy: a rare, potentially treatable neuropathy. Neurol India. 2015;63(1):30.CrossRefPubMed
40.
go back to reference Verschueren A, Gallard J, Boucraut J, Honnorat J, Pouget J, Attarian S. Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer. J Neurol Sci. 2015;358(1):413–6.CrossRefPubMed Verschueren A, Gallard J, Boucraut J, Honnorat J, Pouget J, Attarian S. Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer. J Neurol Sci. 2015;358(1):413–6.CrossRefPubMed
41.
go back to reference Ni J, Weng L, Liu M, Yang H, Wang Y. Small cell lung cancer accompanied by tonsillar metastasis and Anti-Hu antibody-associated paraneoplastic neuropathy: a rare case report with long-term survival. Medicine (Baltimore). 2015;94(50):e2291.CrossRef Ni J, Weng L, Liu M, Yang H, Wang Y. Small cell lung cancer accompanied by tonsillar metastasis and Anti-Hu antibody-associated paraneoplastic neuropathy: a rare case report with long-term survival. Medicine (Baltimore). 2015;94(50):e2291.CrossRef
42.
go back to reference Erdener SE, Vural A, Temucin CM, Ozdamar SE, Nurlu G, Varli K, Dericioglu N. Brachial diparesis due to motor neuronopathy as one of the predominant presenting signs of occult small cell lung carcinoma. Intern Med. 2016;55(12):1641–3.CrossRefPubMed Erdener SE, Vural A, Temucin CM, Ozdamar SE, Nurlu G, Varli K, Dericioglu N. Brachial diparesis due to motor neuronopathy as one of the predominant presenting signs of occult small cell lung carcinoma. Intern Med. 2016;55(12):1641–3.CrossRefPubMed
43.
go back to reference Jarius S, Ringelstein M, Haas J, Serysheva II, Komorowski L, Fechner K, Wandinger KP, Albrecht P, Hefter H, Moser A, Neuen-Jacob E. Inositol 1, 4, 5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy. J Neuroinflamm. 2016;13(1):278.CrossRef Jarius S, Ringelstein M, Haas J, Serysheva II, Komorowski L, Fechner K, Wandinger KP, Albrecht P, Hefter H, Moser A, Neuen-Jacob E. Inositol 1, 4, 5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy. J Neuroinflamm. 2016;13(1):278.CrossRef
44.
go back to reference Zis P, Rao DG, Wagner BE, Nicholson-Goult L, Hoggard N, Hadjivassiliou M. Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma. Cereb Ataxias. 2017;4(1):1.CrossRef Zis P, Rao DG, Wagner BE, Nicholson-Goult L, Hoggard N, Hadjivassiliou M. Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma. Cereb Ataxias. 2017;4(1):1.CrossRef
45.
go back to reference Candler PM, Hart PE, Barnett M, Weil R, Rees JH. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry. 2004;75(10):1411–5.CrossRefPubMedPubMedCentral Candler PM, Hart PE, Barnett M, Weil R, Rees JH. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry. 2004;75(10):1411–5.CrossRefPubMedPubMedCentral
46.
go back to reference Graus F, Keime-Guibert F, Reñe R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(6):1138–48.CrossRefPubMed Graus F, Keime-Guibert F, Reñe R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(6):1138–48.CrossRefPubMed
47.
go back to reference Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50(3):652–7.CrossRefPubMed Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50(3):652–7.CrossRefPubMed
48.
go back to reference Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: a systematic review. J Neurol. 2016;263(10):1903–10.CrossRefPubMed Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: a systematic review. J Neurol. 2016;263(10):1903–10.CrossRefPubMed
49.
go back to reference Kafka SP, Condemi JJ, Marsh DO, Leddy JP. Mononeuritis multiplex and vasculitis: association with anti—neutrophil cytoplasmic autoantibody. Arch Neurol. 1994;51(6):565–8.CrossRefPubMed Kafka SP, Condemi JJ, Marsh DO, Leddy JP. Mononeuritis multiplex and vasculitis: association with anti—neutrophil cytoplasmic autoantibody. Arch Neurol. 1994;51(6):565–8.CrossRefPubMed
50.
go back to reference Vadalouca A, Raptis E, Moka E, Zis P, Sykioti P, Siafaka I. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract. 2012;12(3):219–51.CrossRefPubMed Vadalouca A, Raptis E, Moka E, Zis P, Sykioti P, Siafaka I. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract. 2012;12(3):219–51.CrossRefPubMed
51.
go back to reference Sykioti P, Zis P, Vadalouca A, Siafaka I, Argyra E, Bouhassira D, Stavropoulou E, Karandreas N. Validation of the Greek version of the DN4 diagnostic questionnaire for neuropathic pain. Pain Pract. 2015;15(7):627–32.CrossRefPubMed Sykioti P, Zis P, Vadalouca A, Siafaka I, Argyra E, Bouhassira D, Stavropoulou E, Karandreas N. Validation of the Greek version of the DN4 diagnostic questionnaire for neuropathic pain. Pain Pract. 2015;15(7):627–32.CrossRefPubMed
Metadata
Title
Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis
Authors
Panagiotis Zis
Antonella Paladini
Alba Piroli
Patrick C. McHugh
Giustino Varrassi
Marios Hadjivassiliou
Publication date
01-12-2017
Publisher
Springer Healthcare
Published in
Pain and Therapy / Issue 2/2017
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-017-0076-3

Other articles of this Issue 2/2017

Pain and Therapy 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.